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OBJECTIVES: Provider continuity is defined as seeing the samehealth care provider
over time. Previous studies indicated that high provider continuity improves
health care outcomes and the efficiency of health care delivery. The impact of
provider continuity in sickle cell disease (SCD) care, however, is unknown. This
study examined the association between provider continuity and the risk of SCD-
related hospitalization and re-hospitalization within 30 days of discharge.
METHODS: A retrospective cohort study was conducted using Florida Medicaid
claims data from 2001-2005. Patients with claims containing SCD-related ICD-9
codes (282.41-282.42, 282.6- 282.64, 282.68-282.69) were selected. To be eligible,
individuals had to be aged65 years, continuously enrolled in Medicaid, and have
made2 ambulatory visits.Modifiedmodified continuity index (MMCI) scoreswere
calculated to quantify provider continuity. Cox proportional hazard modeling was
used to examine the relationship between MMCI and hospitalization and 30-day
re-hospitalization controlling for basic demographics, prior utilization, SCD treat-
ments and complications. RESULTS: A total of 2422 patients with mean age of 10.2
(SD11.9) and 47.2% male were included. Average MMCI score was 0.60 (SD0.28),
53.47% had 1 SCD-related hospitalization; of those, 18.8% were re-hospitalized
within 30 days. After controlling for patient-level factors, patients with higher
provider continuity were less likely to be hospitalized (HR0.53, 95% CI: 0.44-0.65),
but MMCI was not significantly associated with 30-day risk of re-hospitalization
(HR0.89, 95% CI0.55-1.43). CONCLUSIONS:Higher provider continuity was asso-
ciated with a lower risk of SCD-related hospitalization in the Florida Medicaid SCD
population, but did not affect the rate of 30-day re-hospitalization. Policies that
improve andmaintain continuity between SCD patients and a single provider may
lead to lower hospitalization rates and possibly lower health care costs.
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OBJECTIVES: Thrombocytopenia, or low blood platelet count, is associated with
disease progression and treatment for several chronic conditions, including liver
disease, cancer, and HIV. Yet, little information describing the impact of thrombo-
cytopenia on patients is available. This study compared indicators of health and
functional status among individuals with and without thrombocytopenia.
METHODS: 1999-2008 National Health and Nutrition Examination Survey
(NHANES) data were used to identify individuals aged 20 years with normal and
low platelets, using a threshold of 150x109/L. Indicators of health and/or functional
status included self-reported general health [1-5 scale, 1excellent], number of
health care visits and overnight hospital stays, days physical health was not good,
inactive days due to physical health, and work limitations. Weighted means and
frequencies were summarized and compared using paired t-tests and chi-squared
tests, respectively. RESULTS: 22,959/25,772 participants aged 20 years had infor-
mation on platelets. Of these, 526 (1.9%) had low platelets at the time of examina-
tion. Individuals with thrombocytopenia were older (51.7 vs 37.2 years) and more
likely to be male (67.7% vs 48.6%), infected with hepatitis C (7.4% vs 1.4%), and ever
diagnosed with cancer (14.2% vs 8.0%) or a liver condition (12.3% vs 3.1%), p.05 for
all. Fewer participantswith thrombocytopenia reported excellent health compared
to those with normal platelets (12.5% vs 16.5%, p.0001). Participants with throm-
bocytopenia reported more health care provider visits (2.35 vs 2.02, p.0001) and
were more likely to report an overnight hospital stay (0.19% vs 0.11%, p.001).
Participants with thrombocytopenia hadmore inactive days due to physical health
and were more likely to face work limitations (p.01 for all). CONCLUSIONS:
Thrombocytopenia is associated with limitations on functional status and in-
creased health care utilization, some of which may be related to patients’ under-
lying health conditions. Further study is needed to determine the incremental
impact of thrombocytopenia.
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OBJECTIVES: Minimal health-related quality of life (HRQOL) data have been pub-
lished on myelodysplastic syndromes (MDS) patients in the United States. This
analysis characterized HRQOL by age group of MDS pts treated with Vidaza® in the
AVIDA® registry.METHODS: Data were collected from AVIDA, a Vidaza treatment
registry, initiated in US community clinics. Clinicians provided patient demo-
graphic, treatment pattern, and clinical outcome data. Patients reported HRQOL
(EORTC-QLQ-C30) within 2 months of treatment initiation. Mean (Standard Devia-
tion [SD]) scores on global health status (GHS), 5 functional scales and 9 symptom/
other scales were analyzed by age: 65, 65-74, 75 years. Statistical significance
was ascertained by ANOVA using SAS 9.1. RESULTS: Data were reported from 99
clinics on 427 pts:65 (n68), 65-74 (n127), and75 (n232) years.Mean (SD) GHS
was 54.8 (1.2) overall, and similar among age groups: 53.9 (2.9), 54.7 (2.1), and 55.2
(1.6), p0.9263. Similarly, physical, role, and social functioning were comparable.
Emotional and cognitive functioning, however, were worse among those 65 ver-
sus the older groups: 66.2 (3.5), 78.6 (1.8), 79.5 (1.5), p0.0001 for emotional, and 72.4
(3.5), 82.7 (1.7), 80.3 (1.4), p0.0067 for cognitive. The 65 cohort reported signifi-
cantly worse scores on 4 of 9 symptom/other scores: financial difficulties (34.8 (4.5),
15.3 (2.4), 13.0 (1.7), p0.0001); insomnia (39.7 (4.0), 27.5 (2.7), 27.3 (2.2), p0.0141);
appetite loss (29.9 (3.8), 18.4 (2.5), 25.3 (2.1), p0263); and fatigue 53.9 (3.1), 44.3 (2.3),
48.5 (1.8), p0.0452). CONCLUSIONS: AVIDA registry findings indicate baseline
HRQOL among MDS patients in real world settings differs by age in certain do-
mains. Findings suggest HRQOL is similar or better in elderly MDS patients than
younger patients. These differences in emotional and cognitive functioning, fa-
tigue, insomnia, appetite loss, and financial difficulties require consideration by
clinicians in managing MDS patients.
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OBJECTIVES: Chronic pain is a major public health concern in the US. Established
guidelines are available formanagement of non-malignant chronic pain, including
opioid use. However, discrepancies in opioid prescribing patterns due to physician
misconceptions remain concerning. Therefore, this study evaluated pain medica-
tion use and investigated determinants of opioid analgesic prescribing in the US
outpatient settings for common non-malignant chronic pain indications.
METHODS: This cross-sectional study analyzed the National Ambulatory Medical
Care Survey(NAMCS) data from 2002-2007 on patients 18 years and older with
non-malignant chronic pain diagnosis based on ICD-9-CM codes identified as rea-
son for visits. Painmedications prescribedwere retrieved usingNAMCSdrug codes.
Multivariate logistic models examined determinants of opioid prescribing among
chronic pain patients. RESULTS: Approximately 69 million weighted outpatient
visits were reported for non-malignant chronic pain between 2000-2007 in the US.
The mean age for patients was 53 (range 18-100) and the majority were
women(63%). Neuropathic pain was reported for 2.39% visits while 16.24% had an
inflammatory pain diagnosis. Non-medication treatment was prescribed during
26% of these visits. While most(95%) visits reported prescribing NSAIDs, 29% re-
ported receiving prescriptions for more than five medications. Primary care physi-
cians (PCPs) were 1.74 times more likely to prescribe opioids [OR(odds ratio):1.74,
CI:1.42-2.14] than other specialty physicians. Patients receiving more than five
medications were 2.80 times more likely to receive opioids (OR:2.80,CI:2.28-3.44)
than thosewith less thanfivemedications. Patients from the southern region of the
US were 1.43 times more likely to receive opioids (OR:1.43,CI:1.06-1.94) than pa-
tients from the northeast region. CONCLUSIONS: According to our study, visits
with PCPs, more than five prescriptions, established patients, and physician visits
in the southern region of the US were some of the determinants of opioid prescrib-
ing. Increased awareness of opioid prescription guidelines for pain management
may eliminate prescription discrepancies and improve patient care.
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OBJECTIVES: This study determined factors associated with treatment choice for
pain management in US nursing home hospice/palliative care residents.
METHODS: This is a cross sectional study of data from the resident file of the 2004
National Nursing Home Survey (NNHS). Residents assigned to a bed in a hospice
specialty unit or receiving services from a special program for hospice/palliative
care in 1174 systematically selected nursing homes and having pain in 7 days
before the surveywere included. Treatment choices included standing order (SO) of
analgesics, as-needed orders (PRN) of analgesics and non-pharmacological treat-
ment (NPT). Factors evaluated were gender, marital status, age, ethnicity, eating
limitation, toilet limitation, urinary incontinence and bowel incontinence.
Weighted descriptive analysis, bivariate analysis using chi-square tests and mul-
tivariate analysis using logistic regression were conducted using SAS version 9.2 to
determine factors associated with pain management. RESULTS: Overall 22.6%
(338,029/1,492,207,weighted) patients met the study inclusion criteria. Mean[SD]
age was 79.1[13.3] years, 74.7% were females and 89.8% were white. 78.6%, 49.8%,
and 29.3% received PRN, SO, and NPT, respectively. Logistic regression showed
higher likeliness to receive SO for patients of age at or above 65 years (OR1.51 95%
CI1.184-1.948 P0.001), patients with bowel incontinence (OR1.21 95%
CI1.020-1.437 P0.028) and Medicaid patients (OR1.5 95% CI1.258-1.799
P0.0001). Likeliness to receive PRN was lower for patients of age at or above 65
years (OR0.60 95% CI0.428-0.841 P0.0031), patients with bowel incontinence
(OR0.67 95%CI0.533-0.859 P0.0014), Medicaid patients (OR0.65 95%CI0.525-
0.806 P0.0001) and Hispanics (OR0.327 95% CI0.204-0.527 P0.001). Likeliness
to receive NPT was higher for patients with toileting limitation (OR2.905 95%
CI1.135-7.434 P0.026) and lower for patients with urinary incontinen-
ce(OR0.022 95% CI0.003-0.172 P0.0003). CONCLUSIONS: Factors affecting
treatment choice were age, bowel and urinary incontinence, toileting limitations,
ethnicity and insurance type and can be targeted in future studies aiming at man-
agement of pain in nursing homes.
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OBJECTIVES: To compare the estimates of Prevalence Ratio (PR) and Odds Ratios
(OR) as effect measures in the analysis of cross sectional data for obese individuals
sufferingwith chronic comorbid conditions.METHODS:Medical Expenditure Panel
Survey data files from 2005-2007 was utilized for the analysis. Obese adults were
defined as individuals with age 20 years and having a BMI 30. Prevalence ratios
were estimated from logistic regressions by dividing predicted prevalence esti-
mates of comorbidities among obese individuals to the predicted prevalence of
comorbidities in non-obese individuals after adjusting for socio-demographic fac-
tors. Ninety-five percent boot-strapped confidence intervals were generated
around the prevalence ratios. Odds ratios were generated by using the ‘Survey
Logistic’ syntax in SAS after adjusting for the same socio-demographic factors.
RESULTS: Both odds ratios and prevalence ratios indicate that obese individuals
have a greater burden of chronic conditions in the United States. Obese individuals
had the greatest odds of having hypertension and osteoarthritis followed by coro-
nary heart disease, diabetes and dyslipidemia. Prevalence ratios were highest for
diabetes, followed by hypertension, osteoarthritis and dyslipidemia. Odds ratios
were almost always greater than the prevalence ratios for all chronic conditions.
The confidence intervals derived around odds ratios were also wider than the
confidence intervals around the prevalence ratios. CONCLUSIONS: The relative
importance of obesity upon different disease conditions differed depending on
whether PR or OR were estimated. This study along with previous literature shows
that odds ratiosmay be overestimating the true effect of a disease condition on the
prevalence of a comorbid disease. Although it is easier to derive odds ratios, prev-
alence ratiosmay bemore realistic estimates of the true public health burden. Thus
prevalence ratios should ideally be used as effect measures instead of odds ratios
especially for commonly occurring disease conditions.
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OBJECTIVES:The objective of knowledge study (TOCKS)was to quantify the patient
burden and to characterize patient symptomatology and acceptance of treatment
with anakinra in Cryopyrin-associated Periodic Syndrome (CAPS), an orphan dis-
ease. Additionally, chart review and patient recall of symptoms, adverse events,
and resource use were compared. The aforementioned objectives were completed
through the use of a unique online approach to gathering data and rapidly display-
ing the results.METHODS: This retrospectivemedical chart review and concurrent
online patient survey, conducted in Centers of Excellence for CAPS in Europe, was
accomplished by analyzing data entered via internet-based case report forms
(CRFs). Data were entered into the CRFs by both study groups for two distinct
collection periods—prior to and during the most recent 12 months of anakinra
treatment. RESULTS: Four sites (50 patients total) participated in TOCKS. Prior to
entering data, users viewed an online tutorial to help in completing the survey. No
patients were lost to follow up and the data were successfully collected, analyzed,
and reviewed via the online CRF and dynamically-generated data tables. This in-
novative online approach allowed users to enter de-identified data, in multiple
sessions, even in the most remote destinations. One patient successfully com-
pleted their survey in the Amazon. In addition, a unique identifier was randomly
generated that linked chart review with patient recall data online. Site investiga-
tors were also able to view the dynamic tables and reports online and benchmark
themselves against the other, encrypted, sites. CONCLUSIONS: This novel internet
technology allowed for efficient data collection from multiple sites and multiple
sources within a short time frame. The unique identifier made it effortless to col-
lect and compare the entries from the chart and from the patients for the same
patient.
PSY77
COMPARISON OF OBESITY-ASSOCIATED COMORBIDITIES BETWEEN EMR AND
CLAIMS DATABASES
Brixner D1, Bron M2, Bellows BK1, Ye X1, Harikrishnan V2, Oderda G1
1University of Utah, Salt Lake City, UT, USA, 2Takeda Pharmaceuticals International, Inc.,
Deerfield, IL, USA
OBJECTIVES: To compare rates of obesity-associated comorbidities between the
General Electric (GE) Centricity EMR and Thomson Reuters MedStat MarketScan
commercial claims databases in patients with either a recorded BMI 25 (GE EMR)
or ICD-9 code for overweight/obesity (MarketScan). METHODS: From the GE EMR,
subjects aged 20-64 with at least one BMI value 25 and 2 y of EMR activity prior
to BMI index date were included. FromMarketScan, subjects 20 y (mostly 65 y),
with a claim (ICD-9 code) for overweight, obesity, ormorbid obesity, and365 days
of claims activity after selected comorbidity was first recorded, were included.
Selected comorbidities were identified by ICD-9 codes in both databases and strat-
ified by BMI or overweight/obesity claims. RESULTS: In the GE EMR, 109,885 sub-
jects (36.7%) were overweight or obese (BMI 25). Of these, 51% had BMI 25-29.9,
28% had BMI 30-34.9, and 22% had BMI 35. In the MarketScan database, 246,261
subjects (0.7%) had overweight, obesity, ormorbid obesity claims. Of these, 4%were
overweight, 66% were obese, and 30% were morbidly obese. The three most prev-
alent comorbidities in both databases, across all weight categories, were hyperten-
sion, hyperlipidemia, and chronic back pain, except diabetes replaced back pain in
the morbid obesity group in MarketScan. For all comorbidities, prevalence was
higher in MarketScan, except polycystic ovary syndrome prevalence was higher in
GE EMR BMI 35 group compared to morbid obesity group in MarketScan.
CONCLUSIONS: Despite different methods (BMI vs. ICD-9 codes) for capturing obe-
sity between two databases, prevalence rankings of comorbidities were similar.
Obesity is therapeutically classified by BMI; however, most large claims databases
capture obesity by ICD-9 codes. This may result in variation in weight group dis-
tributions and significant under-reporting of obesity claims in MarketScan. Our
findings highlight the need for further research in optimal sources for data in obese
patients.
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OBJECTIVES: This study tests a flexible modeling approach, which endogenously
estimates the non-linear and asymmetric functional form for body mass index
(BMI), to examine the relationship betweenmortality and obesitymeasured as BMI
30. METHODS: This study used the National Health Interview Survey (NHIS),
between 1997 and 2000. Respondents were linked to the National Death Index with
mortality follow-up through 2005. We estimated the 5-year probability of death
using the logistic regression model adjusting for BMI, age and sex. The multivari-
able fractional polynomials (MFP) procedure was employed to determine the best
fitting functional form for BMI and compared to alternative functional forms using
a chi-squared test. Expected years of life lost due to obesity were based on adjusted
death probabilites and computed using standard life table functions.RESULTS:The
best fitting adjustment model contains the powers 1 and 2 for BMI. A chi-
squared test shows a statistically significant improvement in model fit compared
to other BMI polynomial functions. The estimated relationship between 5-year
probability of death and BMI exhibits a J-shaped pattern forwomen and aU-shaped
pattern for men. The BMI associated with minimum mortality is 27.53 for males
and 25.19 for females. A 40-year-old female with a BMI of 40 has an estimated 5.82
fewer years of expected life compared to an analogous female with a BMI of 25. For
a comparable change in BMI in a 40-year-old male, the expected years of life lost is
5.20. CONCLUSIONS: The BMI-mortality relation is flat around the minimum, but
especially highmortality is associated with themorbidly obese. TheMFP approach
provides a robust alternative to estimating mortality by allowing the data to deter-
mine the best fitting model. The approach is also useful in estimating the relation-
ship between the full spectrum of BMI values and other health outcomes.
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OBJECTIVES: The MusiQOL questionnaire was co-developed in 15 countries to as-
sess the quality of life of patientswithMultiple Sclerosis. The objective of this study
was to test the cultural relevance of the instrument in 4 Arabic countries (Egypt,
Morocco, Saudi Arabia and Tunisia) and Iran, not involved in the initial develop-
ment, and to assess the conceptual equivalence of the translations with the UK
original used as a basis for translation.METHODS: In each country, the translation
process was conducted by a linguistic expert, using either the standard forward/
backward methodology or the adjusted process (adaptation from the Saudi Arabia
version), including cognitive interviews with 6 patients. The basis for discussion
was the concept list developed in collaborationwith the author. RESULTS: Linguis-
tic and cultural issues emerged during the translation process. First, the acronym
“MS” used throughout the original version for ”Multiple Sclerosis” was replaced by
the full name in Arabic countries for clarity, but not in Iran where the patients
preferred the abbreviation. Second, using euphemistic expressions for taboo con-
cepts such as sex life proved necessary to ensure homogenous response across all
languages without any negative connotation. Finally, leisure activities (e.g. shop-
ping, going out to amovie, gardening) described in the original had to be adapted to
the religious and social context in the target countries. CONCLUSIONS: The 5 lan-
guage versions of the MusiQol were established following a proven standardized
methodology, on the basis of a concept list worked out with the author, to allow
international data pooling and mining whilst addressing the specific challenges of
regional adaptation. The process as a whole supports the advantage of integrating
continuous and diverse international feedback on wording during the linguistic
validation process.
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OBJECTIVES: The IQWiG’s method provides a concept for the drawing of an effi-
ciency limit and its extrapolation to the assessment of the cost-benefit relation.
Here benefits are to be assessed in terms of a set of clinical endpoints. PREs might
include different issues of mortality, morbidity and health-related quality of life as
well as other important factors identified as being patient-relevant. Efficiency fron-
tiers cannot be drawn for all possible outcomes, it is important to determinewhich
factors are most relevant to patients. IQWiG allows different efficiency frontiers.
How can contradictory results be interpreted? The problemwithin the utility mea-
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